Microinvasive ductal carcinoma of the breast. Role of sentinel lymph node biopsy;Cancer canalaire in situ du sein avec micro-invasion. Place du ganglion sentinelle

Gynecologie Obstetrique et Fertilite

Volumn 35, Issue 4, 2007, Pages 317-322

  Le Bouedec G ^a   de Lapasse, C ^a   Mishellany, F ^a   Chene G ^a   Michy, T ^a   Gimbergues, P ^a   Dauplat, J ^a  

^a CENTRE JEAN PERRIN   (France)

Author keywords

Microinfiltrating breast cancer; Sentinel lymph node

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MICROMETASTASIS; SENTINEL LYMPH NODE BIOPSY;

EID: 34047268909     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2006.12.024     Document Type: Article

References (41)

1. de Roquancourt A., Cottu P.H., Cuvier C., Nowak H., and Espie M. Cancers canalaires in situ. Presse Med. 32 (2003) 134-140
2. Cutuli B., Fourquet A., Luporsi E., Arnould L., Caron Y., de Cremoux P., et al. Recommandations pour la pratique clinique : Standards, Options et Recommandations 2004 pour la prise en charge des carcinomes canalaires in situ du sein (rapport abrégé). Bull. Cancer 92 (2005) 155-168
3. Burstein H.J., Polyak K., Wong J.S., Lester S.C., and Kaelin C.M. Ductal carcinoma in situ of the breast. N. Engl. J. Med. 350 (2004) 1430-1441
4. Leonard G.D., and Swain S.M. Ductal carcinoma in situ, complexities and challenges. J. Natl. Cancer Inst. 96 (2004) 906-920
5. Silver S.A., and Tavassoli F.A. Mammary ductal carcinoma in situ with microinvasion. Cancer 82 (1998) 2382-2390
6. Ellis I.O., Lee A.H.S., Elston C.W., and Pinder S.E. Microinvasive carcinoma of the breast : diagnostic criteria and clinical relevance. Histopathology 35 (1999) 468-472
7. Padmore R.F., Fowble B., Hoffman J., Rosser C., Hanlon A., and Patchefsky A.S. Microinvasive breast carcinoma. Clinicopathologic analysis of a single institution experience. Cancer 88 (2000) 1403-1409
8. Prasad M.L., Osborne M.P., Giri D.D., and Hoda S.A. Microinvasive carcinoma (T1mic) of the breast. Clinicopathologic profile of 21 cases. Am. J. Surg. Pathol. 24 (2000) 422-428
9. de Mascarel I., MacGrogan G., Mathoulin-Pélissier S., Soubeyran I., Picot V., and Coindre J.M. Breast ductal carcinoma in situ with microinvasion. A definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer 94 (2002) 2134-2142
10. Le Bouëdec G., Gimbergues P., Feillel V., Penault-Llorca F., and Dauplat J. Cancers canalaires in situ du sein avec micro-invasion. Quelle exploration ganglionnaire axillaire?. Presse Med. 34 (2005) 208-212
11. Delahaye S., Benamor M., Nos C., Vincent-Salomon A., El Khoury C., Sigal-Zafrani B., et al. Le ganglion sentinelle en routine dans le cancer du sein : expérience de l'Institut Curie. Bull. Cancer 91 (2004) 641-647
12. Giard S., Chauvet M.P., Houpeau J.L., Baranzelli M.C., Carpentier P., Fournier C., et al. Le ganglion sentinelle sans curage systématique dans le cancer du sein : bilan d'une expérience de 1000 interventions. Gynecol. Obstet. Fertil. 33 (2005) 213-219
13. Lee C.H., Carter D., Philpotts L.E., Couce M.E., Horvath L.J., Lange R.C., et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy : can invasion be predicted?. Radiology 217 (2000) 466-470
14. King T.A., Farr G.H., and Cederbom G.J. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ. Am. Surg. 67 (2001) 907-912
15. Yen T.W.F., Hunt K.K., Ross M.I., Mirza N.Q., Babiera G.V., Meric-Bernstam F., et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ : a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J. Am. Coll. Surg. 200 (2005) 516-526
16. Lagios M.D., and Silverstein M.J. Sentinel node biopsy for patients with DCIS : a dangerous and unwarranted direction. Ann. Surg. Oncol. 8 (2001) 275-277
17. Farkas E.A., Stolier A.J., Teng S.C., Bolton J.S., and Furhrman G.M. An argument against routine sentinel node mapping for DCIS. Am. Surg. 70 (2004) 13-17
18. Veronesi P., Intra M., Vento A.R., Naninato P., Caldarella P., et al. Sentinel lymph node biopsy for localised ductal carcinoma in situ?. Breast 14 (2005) 520-522
19. Cox E.C., Nguyen K., Gray R.J., Salud C., Ku N.N., Dupont E., et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?. Am. Surg. 67 (2001) 513-521
20. Klauber-DeMore N., Tan L.K., Liberman L., Kaptain S., Fey J., Borgen P., et al. Sentinel lymph node biopsy : is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?. Ann. Surg. Oncol. 7 (2000) 636-642
21. McMasters K.M., Chao C., Wong S.L., Martin III R.C.G., and Edwards M.J. Sentinel lymph node biopsy in patients with ductal carcinoma in situ. A proposal. Cancer 95 (2002) 15-20
22. Buttarelli M., Houvenaeghel G., Martino M., Rossi I., Ronda I., Ternier F., et al. Prélèvement de ganglions sentinelles dans les carcinomes intracanalaires du sein (± micro-invasion). Ann. Chir. 129 (2004) 508-512
23. Moran C.J., Kell M.R., and Kerin M.J. The role of sentinel lymph node biopsy in ductal carcinoma in situ. Eur. J. Surg. Oncol. 31 (2005) 1105-1111
24. Recommandations européennes pour l'assurance de qualité dans le cadre du dépistage mammographique du cancer du sein. Rapport des anatomopathologistes du groupe de travail "Dépistage du cancer du sein" de l'Union Européenne. Ann. Pathol. 16 (1996) 315-333
25. Maublant J., Cachin F., Mestas D., and Geissler B. Le repérage du ganglion sentinelle en médecine nucléaire. Bull. Cancer 89 (2002) 671-680
26. Parker R.G., Berkbigler D., Rees K., Leung K.M., and Legorreta A.P. Axillary node dissection in ductal carcinoma in situ. Am. J. Clin. Oncol. 21 (1998) 109-110 (CCT)
27. Kelly T.A., Kim J.A., Patrick R., Grundfest S., and Crowe J.P. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am. J. Surg. 186 (2003) 368-370
28. Zavotsky J., Hansen N., Brennan M.B., Turner R.R., and Giuliano A.E. Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer 85 (1999) 2439-2443
29. Wong S.L., Chao C., Edwards M.J., Carlson D.J., Laioley A., Noyes R.D., et al. Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes. Am. J. Surg. 184 (2002) 492-498
30. Wilkie C., White L., Dupont D., Cantor A., and Cox C.E. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am. J. Surg. 190 (2005) 563-566
31. Houvenaeghel G., Nos C., Mignotte H., Classe J.M., Giard S., Rouanet P., et al. Micrometastases in sentinel lymph node in a multicentric study : predictive factors of nonsentinel lymph node involvement - Groupe des Chirurgiens de la Fédération des Centres de Lutte Contre le Cancer. J. Clin. Oncol. 12 (2006) 1814-1822
32. Tamhane R., Dahlstrom J.E., McCallum D.D., and Buckingham J.M. The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ. Ann. Surg. Oncol. 9 (2002) 999-1003
33. Lara J.F., Young S.M., Velilla R.E., Santoro E.J., and Templeton S.F. The relevance of occult axillary micrometastasis in ductal carcinoma in situ. A clinicopathologic study with long-term follow-up. Cancer 98 (2003) 2105-2113
34. El-Tamer M., Chun J., Gill M., Bassi D., Lee S., Hibshoosh H., et al. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ. Ann. Surg. Oncol. 12 (2005) 254-259
35. Seror J.Y., Antoine M., Scetbon F., Chopier J., Sananes S., Ghenassia C., et al. Apport des macrobiopsies stéréotaxiques par aspiration dans la prise en charge des microcalcifications mammaires : première série prospective de 115 cas. Gynecol. Obstet. Fertil. 28 (2000) 806-819
36. Jackman R.J., Burbank F., and Parker S.H. Stereotactic breast biopsy of non palpable lesions : determinants of ductal carcinoma underestimation rates. Radiology 218 (2001) 497-502
37. Hoorntje L.E., Schipper M.E., and Peeters P.H. The finding of invasive cancer after preoperative diagnosis of ductal carcinoma in situ : causes of ductal carcinoma in situ underestimates with stereotactic 14 gauge needle biopsy. Ann. Surg. Oncol. 10 (2003) 748-753
38. Goyal A., Douglas-Jones A., Monypenny I., Sweetland H., Stevens G., and Mansel R.E. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases. Breast Cancer Res. Treat. 98 (2006) 311-314 (in press)
39. Luini A., Galimberti V., Gatti G., Arnone P., Vento A.R., Trifiro G., et al. The sentinel node biopsy after previous breast surgery : preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res. Treat. 89 (2005) 159-163
40. Heuts E.M., van der Ent F.W., Kengen R.A., van der Pol H.A., Hulsewé K.W., and Hoofwijk A.G. Results of sentinel node biopsy not affected by previous excisional biopsy. Eur. J. Surg. Oncol. 32 (2006) 278-281
41. Antoine M. Pour le recours à l'histologie dans le diagnostic des tumeurs du sein. Gynecol. Obstet. Fertil. 33 (2005) 540-542